Cubberley R R, Alderton W K, Boyhan A, Charles I G, Lowe P N, Old R W
GlaxoWellcome, Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts. SG1 2NY, UK.
Biochem J. 1997 Apr 1;323 ( Pt 1)(Pt 1):141-6. doi: 10.1042/bj3230141.
Nitric oxide synthase (EC 1.14.13.39) is a homodimer. Limited proteolysis has previously shown that it consists of two major domains. The C-terminal or reductase domain binds FMN, FAD and NADPH. The N-terminal or oxygenase domain is known to bind arginine, (6R)-5,6,7,8-tetrahydro-l-biopterin (tetrahydrobiopterin) and haem. The exact residues of the inducible nitric oxide synthase (iNOS) protein involved in binding to these molecules have yet to be identified, although the haem moiety is known to be co-ordinated through a cysteine thiolate ligand. We have expressed two forms of the haem-binding domain of human iNOS (residues 1-504 and 59-504) in Escherichia coli as glutathione S-transferase (GST) fusion proteins. The iNOS 1-504 and 59-504 fusion proteins bound similar amounts of haem, Nomega-nitro-l-arginine (nitroarginine) and tetrahydrobiopterin, showing that the first 58 residues are not required for binding these factors. Using site-directed mutagenesis we have mutated Cys-200, Cys-217, Cys-228, Cys-290, Cys-384 and Cys-457 to alanine residues within the iNOS 59-504 haem-binding domain. Mutation of Cys-200 resulted in a complete loss of haem, nitroarginine and tetrahydrobiopterin binding. Mutants of Cys-217, Cys-228, Cys-290, Cys-384 or Cys-457 showed no effect on the haem content of the fusion protein, no effect on the reduced CO spectral peak (444 nm) and were able to bind nitroarginine and tetrahydrobiopterin at levels equivalent to the wild-type fusion protein. After removal of the GST polypeptide, the wild-type iNOS 59-504 domain was dimeric, whereas the C200A mutant form was monomeric. When the mutated domains were incorporated into a reconstructed full-length iNOS protein expressed in Xenopus oocytes, only the Cys-200 mutant showed a loss of catalytic activity: all the other mutant iNOS proteins showed near wild-type enzymic activity. From this systematic approach we conclude that although Cys-217, Cys-228, Cys-290, Cys-384 and Cys-457 are conserved in all three NOS isoforms they are not essential for cofactor or substrate binding or for enzymic activity of iNOS, and that Cys-200 provides the proximal thiolate ligand for haem binding in human iNOS.
一氧化氮合酶(EC 1.14.13.39)是一种同型二聚体。此前的有限蛋白酶解研究表明,它由两个主要结构域组成。C末端或还原酶结构域结合FMN、FAD和NADPH。已知N末端或加氧酶结构域结合精氨酸、(6R)-5,6,7,8-四氢-l-生物蝶呤(四氢生物蝶呤)和血红素。尽管已知血红素部分通过半胱氨酸硫醇盐配体进行配位,但参与结合这些分子的诱导型一氧化氮合酶(iNOS)蛋白的确切残基尚未确定。我们在大肠杆菌中表达了两种形式的人iNOS血红素结合结构域(残基1-504和59-504),作为谷胱甘肽S-转移酶(GST)融合蛋白。iNOS 1-504和59-504融合蛋白结合的血红素、Nω-硝基-l-精氨酸(硝基精氨酸)和四氢生物蝶呤量相似,表明结合这些因子不需要前58个残基。我们使用定点诱变技术,将iNOS 59-504血红素结合结构域内的半胱氨酸-200、半胱氨酸-217、半胱氨酸-228、半胱氨酸-290、半胱氨酸-384和半胱氨酸-457突变为丙氨酸残基。半胱氨酸-200的突变导致血红素、硝基精氨酸和四氢生物蝶呤结合完全丧失。半胱氨酸-217、半胱氨酸-228、半胱氨酸-290、半胱氨酸-384或半胱氨酸-457的突变体对融合蛋白的血红素含量没有影响,对还原型CO光谱峰(444 nm)没有影响,并且能够以与野生型融合蛋白相当的水平结合硝基精氨酸和四氢生物蝶呤。去除GST多肽后,野生型iNOS 59-504结构域是二聚体,而C200A突变体形式是单体。当将突变结构域整合到非洲爪蟾卵母细胞中表达的重组全长iNOS蛋白中时,只有半胱氨酸-200突变体表现出催化活性丧失:所有其他突变型iNOS蛋白都表现出接近野生型的酶活性。通过这种系统方法我们得出结论,尽管半胱氨酸-217、半胱氨酸-228、半胱氨酸-290、半胱氨酸-384和半胱氨酸-457在所有三种NOS同工型中都是保守的,但它们对于iNOS的辅因子或底物结合或酶活性不是必需的,并且半胱氨酸-200为人类iNOS中的血红素结合提供近端硫醇盐配体。